drugset / Trial / NCT06596122
Vitamin D Supplementation in Breast Cancer Patients
RandomizedParallel-groupSingle-blindPrevention
Summary
It is a randomized clinical trial aimed at exploring the neuroprotective effect of vitamin D3 (Cholecalciferol) supplementation in conjunction with paclitaxel-based chemotherapy among breast cancer patients with vitamin D insufficiency or deficiency.
Timeline
- Start
- 2024-10-15
- Primary completion
- 2026-11-30
- Completion
- 2026-12-30
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Cholecalciferol | Other / unclassified | 100000 iu | Oral |